Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1967 1
1968 1
1969 1
1970 3
1971 2
1972 3
1973 2
1974 1
1975 2
1978 1
1979 2
1983 4
1984 5
1985 3
1986 4
1987 8
1988 9
1989 8
1990 8
1991 8
1992 12
1993 9
1994 15
1995 7
1996 25
1997 12
1998 11
1999 16
2000 15
2001 15
2002 12
2003 13
2004 9
2005 13
2006 11
2007 12
2008 23
2009 10
2010 19
2011 19
2012 23
2013 24
2014 27
2015 18
2016 17
2017 15
2018 17
2019 16
2020 22
2021 19
2022 17
2023 15
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

559 results

Results by year

Filters applied: . Clear all
Page 1
Doxorubicin: the good, the bad and the ugly effect.
Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. Carvalho C, et al. Curr Med Chem. 2009;16(25):3267-85. doi: 10.2174/092986709788803312. Epub 2009 Sep 1. Curr Med Chem. 2009. PMID: 19548866 Review.
The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense d …
The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinoma …
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. ...
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. ...
Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.
Bhagat A, Kleinerman ES. Bhagat A, et al. Adv Exp Med Biol. 2020;1257:181-192. doi: 10.1007/978-3-030-43032-0_15. Adv Exp Med Biol. 2020. PMID: 32483740 Review.
Despite its effectiveness, cardiotoxicity is a major late effect that compromises the survival and quality of life of survivors of this and other cancers. Cardiotoxicity is the inability of the heart to pump blood through the body effectively. Doxorubicin-induced cardiotox …
Despite its effectiveness, cardiotoxicity is a major late effect that compromises the survival and quality of life of survivors of this and …
Primary Cardiac Osteosarcoma.
Wang JG, Liu B, Gao H, Li YJ, Zhao P, Liu XP. Wang JG, et al. Heart Lung Circ. 2016 Jul;25(7):698-704. doi: 10.1016/j.hlc.2016.01.006. Epub 2016 Feb 11. Heart Lung Circ. 2016. PMID: 26907617 Review.
BACKGROUND: Primary cardiac osteosarcoma is extremely rare. There is no cohort study on such tumours to date. ...The clinical manifestations, imaging features, and laboratory tests of the primary cardiac osteosarcomas were similar to other types of primary cardia
BACKGROUND: Primary cardiac osteosarcoma is extremely rare. There is no cohort study on such tumours to date. ...The clinical manifes …
Surgery for Tumors of the Heart.
Yanagawa B, Mazine A, Chan EY, Barker CM, Gritti M, Reul RM, Ravi V, Ibarra S, Shapira OM, Cusimano RJ, Reardon MJ. Yanagawa B, et al. Semin Thorac Cardiovasc Surg. 2018 Winter;30(4):385-397. doi: 10.1053/j.semtcvs.2018.09.001. Epub 2018 Sep 8. Semin Thorac Cardiovasc Surg. 2018. PMID: 30205144 Review.
Most surgeons will encounter only a handful of primary cardiac tumors outside of myxomas. Approximately 3 quarters of primary cardiac tumors are benign and 1 quarter is malignant. ...Secondary tumors to the heart are 30 times more frequent than primary car
Most surgeons will encounter only a handful of primary cardiac tumors outside of myxomas. Approximately 3 quarters of primary card
Management of primary cardiac paraganglioma.
Chan EY, Ali A, Umana JP, Nguyen DT, Hamilton DJ, Graviss EA, Ravi V, MacGillivray TE, Reardon MJ. Chan EY, et al. J Thorac Cardiovasc Surg. 2022 Jul;164(1):158-166.e1. doi: 10.1016/j.jtcvs.2020.09.100. Epub 2020 Oct 3. J Thorac Cardiovasc Surg. 2022. PMID: 33148444 Review.
The objective of this study is to examine the management and outcomes for cardiac paraganglioma treatment when cared for by a multidisciplinary cardiac tumor team. METHODS: We reviewed our institutionally approved cardiac tumor database from March 2004 to Jun …
The objective of this study is to examine the management and outcomes for cardiac paraganglioma treatment when cared for by a multidi …
Imaging cardiac tumors.
Kalra MK, Abbara S. Kalra MK, et al. Cancer Treat Res. 2008;143:177-96. doi: 10.1007/978-0-387-75587-8_7. Cancer Treat Res. 2008. PMID: 18619218 Review.
Cross-sectional imaging techniques such as echocardiography and MRI provide important information about cardiac masses. Echocardiography can provide information about cardiac tumors with regard to size, location and response to treatment. MRI is helpful in determini …
Cross-sectional imaging techniques such as echocardiography and MRI provide important information about cardiac masses. Echocardiogra …
Surgical and multimodality treatment of cardiac sarcomas: A systematic review and meta-analysis.
Torabi S, Arjomandi Rad A, Vardanyan R, Lopuszko AT, Van den Eynde J, Zubarevich A, Sá MPBO, Szczechowicz M, Weymann A. Torabi S, et al. J Card Surg. 2021 Jul;36(7):2476-2485. doi: 10.1111/jocs.15538. Epub 2021 Apr 2. J Card Surg. 2021. PMID: 33797789 Review.
INTRODUCTION: Primary cardiac sarcomas (PCSs) are an extremely rare and aggressive type of malignancies that have been described only by a limited number of observational studies. ...
INTRODUCTION: Primary cardiac sarcomas (PCSs) are an extremely rare and aggressive type of malignancies that have been describ …
Neoplastic Pericardial Disease.
Maleszewski JJ, Anavekar NS. Maleszewski JJ, et al. Cardiol Clin. 2017 Nov;35(4):589-600. doi: 10.1016/j.ccl.2017.07.011. Epub 2017 Sep 6. Cardiol Clin. 2017. PMID: 29025549 Review.
Primary cardiac synovial sarcoma.
Wang JG, Li NN. Wang JG, et al. Ann Thorac Surg. 2013 Jun;95(6):2202-9. doi: 10.1016/j.athoracsur.2013.01.030. Epub 2013 May 3. Ann Thorac Surg. 2013. PMID: 23647858 Review.
Primary cardiac synovial sarcoma is an extremely rare entity. The clinical and pathologic characteristics are still poorly understood, and prognostic factors influencing overall survival are still unknown. ...
Primary cardiac synovial sarcoma is an extremely rare entity. The clinical and pathologic characteristics are still poorly und …
559 results